Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results.
Catalent develops. With our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products.
Catalent delivers. As the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments.
Catalent supplies. Globally positioned to serve all your manufacturing and commercial packaging needs, we provide integrated solutions to take your product from design, to clinical trial, to plant, and to pharmacy.
Catalent. More products. Better treatments. Reliably supplied.™
Closing share price
|FY, 2012||FY, 2013||FY, 2014||FY, 2015||FY, 2016|
|$1.83 B||$1.83 B||$1.85 B|
Cost of goods sold
|$1.14 B||$1.23 B||$1.23 B||$1.22 B||$1.26 B|
|$599 M||$615 M||$588 M|
|$241 M||$260 M||$218 M|
|$15.2 M||$210 M||$111 M|
Operating cash flow
|$-32 M||$76.9 M||$-19.7 M|